Pareteum and Artilium Announce Agreement for Pareteum to Acquire Artilium in $104.7 Million Transaction
Fortive Announces Binding Offer to Acquire the Advanced Sterilization Products Business from Johnson & Johnson
Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox
TJR Coatings Inc. Announces Change of Name to “DigiCrypts Blockchain Solutions Inc.” and Results of Annual General and Special Meeting
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
Cryptanite Launches CryptaKings.com to Help Investors Learn About and Improve Trading in Top-Performing Cryptocurrencies
City of Coachella Ratifies Approval of Conditional Use Permit (CUP) for High Hampton’s CoachellaGro Operation to Cultivate Medicinal Cannabis
Cobalt Power Group announces closing of the acquisition of the Ontario Cobalt block in Cobalt mining camp, Ontario
RISE Life Science Corp. to Acquire California CBD Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind
Nevada Sunrise Acquires Option to Purchase Coronado VMS Property in Nevada and Announces Private Placement
Zinc One Reports Final Drill Results from the High-Grade Zinc Discovery at Mina Chica Zone, Bongara Zinc Mine Project, Peru
FSD Pharma Secures Exclusive Rights in Canada for Line of Proprietary Products and Premium Access to Cannabinoid Science Research Platform in Israel
AVITA Medical Announces Institutional Placement of A$16.0 Million to Support U.S. Commercialization of the RECELL Device
Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition
Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix
Exro Technologies Inc. and Lithium Werks Announce Collaboration to Improve Lithium Battery Performance Under Variable Conditions